RealFeedApp beta
Top science & technology news, August 28, 2026
- Dynamic fMRI networks of human emotion
Study identifies four brain networks with unique spatial and temporal features during emotional tasks.
- Benchmark evaluates AI agents on scientific research workflows
New benchmark tests AI agents on real research workflows. Includes 70 tasks across multiple scientific fields.
- AI Reveals Cerebello-Prefront,al Signature of Schizophrenia Symptoms
The model identifies disease-specific brain regions linked to symptom severity in schizophrenia.
- A Secret Anti-Aging Drug and Joining Virtual Power Plants
Startup claims to have found a drug that makes blood young. Article covers longevity and tech.
- Mitochondrial dysfunction as a hallmark of brain senescence in telomerase-deficient mice
Mitochondrial function and energy metabolism are disrupted in telomerase-deficient mice.
- BTT starts human trial using heat therapy for ALS
BTT Medical Institute begins first-in-human trial of heat therapy for ALS using a noninvasive temperature management system.
- GLM-5.3 is now open-weight
Z.ai has released GLM-5.3, its most capable model for coding and cyber defense, as an open-weight model.
- Noradrenergic infraslow rhythm during sleep links heart-rate dynamics and memory
Heart rate fluctuations during NREM sleep are phase-locked to NE rhythms, showing LC's role in very-low-frequency HR variability.
- Anthropic's new hardware standard lets AI agents control the physical world
Anthropic's Model Hardware Standard (MHS) enables AI agents to interface with and control physical devices, streamlining integration and data sharing between devices.
- Startup claims to have found a drug to make your blood young
A startup claims its drug combination could rejuvenate blood, targeting aging processes.
- Attimet (YC F24) is hiring technical staff
Attimet is hiring technical staff to work on AI-powered systems. The focus is on building infrastructure and tools for experimentation and operations.
- AusperBio raises $120M to advance hepatitis B oligo therapy through phase 3
AusperBio has raised $120 million to advance its oligonucleotide therapy for chronic hepatitis B through phase 3 trials.
- Metal binding site alignment reveals protein geometry patterns and drug targets
New method identifies recurring geometries in metal-binding sites across diverse proteins.
- Quantum-enhanced ghost imaging recognition through optimized speckle patterns and quantum parameters
The method combines classical convolution with quantum network optimization to improve recognition accuracy in low-sampling environments.
- 5-year-old brain organoids reveal epigenetic aging dynamics
Brain organoids cultured for 5 years show epigenetic aging patterns similar to those in living organisms.
- BioNTech-Genentech Cancer Vaccine Causes More Deaths Than Control in Scrapped Phase 2 Trial
Cancer vaccine from BioNTech and Genentech led to more deaths than the control group, prompting the halt of a phase 2 trial.
- Leaky oocytes trigger cGAS–STING signaling in aging
Mitochondrial DNA leakage into aged oocytes activates the cGAS–STING pathway, leading to sterile inflammation in the ovary.
- Elon Musk’s xAI used child porn to train Grok models, lawsuit says
xAI faces lawsuit alleging use of child sex abuse materials to train Grok models, with some users arrested over the issue.
- Senolytic Treatments Remove Harmful Senescent Microglia from Aging Brain
Study shows senolytics improve microglia health in aged mice brains. Limited human trials exist for neurodegenerative diseases.
- PhoneLLM Alpha 1: Open-weight LLM for voice agent use cases
PhoneLLM is faster and cheaper than large models, suitable for customer service tasks.
